Physician profile
Michael A King
NPI 1457318305
$1,214.85
in general payments reported to CMS, 2019-2025
12 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $35.99 · 2021: $152 · 2022: $74.87 · 2023: $211 · 2024: $174 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $501.64 | 2021-2025 | O-Arm, Catalyft Pl Expandable Interbody System, Capstone Ptc Spinal System |
| Medtronic USA, INC. | $408.11 | 2019-2020 | |
| Corelink, LLC | $100.00 | 2021 | |
| Stryker Corporation | $39.13 | 2023 | Monterey Al |
| Baxter Healthcare | $35.50 | 2024 | Floseal |
| Djo, LLC | $25.72 | 2025 | Cmf |
| Abbott Laboratories | $25.43 | 2024 | Proclaim |
| Orthofix Medical, INC. | $20.46 | 2023 | Cervical-Stim, Spinal-Stim, Physio-Stim |
| Ethicon US, LLC | $16.34 | 2023 | Dermabond Prineo, Stratafix |
| Zimvie INC. | $15.20 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $14.88 | 2019 | |
| Abbvie INC. | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.